PLX and PBDA Related Headlines
Go Back- Protalix BioTherapeutics Reports First Quarter 2026 Financial and Business Results
- Protalix BioTherapeutics to Announce First Quarter 2026 Financial Results and Business Update on May 13, 2026
- Protalix BioTherapeutics to Announce Fiscal Year 2025 Financial Results and Business Update on March 18, 2026
- Protalix BioTherapeutics Letter to Stockholders
- Protalix BioTherapeutics Reports Third Quarter 2025 Financial and Business Results
- Protalix BioTherapeutics to Announce Third Quarter 2025 Financial and Business Results on November 13, 2025
- Protalix BioTherapeutics Reports Second Quarter 2025 Financial and Business Results
- Protalix BioTherapeutics to Announce Second Quarter 2025 Financial and Business Results on August 14, 2025
- Protalix BioTherapeutics Added to Russell 3000® and 2000 Indexes®
PLX and PBDA Related Press Releases
Go Back- Protalix BioTherapeutics Reports First Quarter 2026 Financial and Business Results
- Protalix BioTherapeutics to Announce First Quarter 2026 Financial Results and Business Update on May 13, 2026
- Protalix BioTherapeutics to Announce Fiscal Year 2025 Financial Results and Business Update on March 18, 2026
- Protalix BioTherapeutics Letter to Stockholders
- Protalix BioTherapeutics Reports Third Quarter 2025 Financial and Business Results
- Protalix BioTherapeutics to Announce Third Quarter 2025 Financial and Business Results on November 13, 2025
- Protalix BioTherapeutics Reports Second Quarter 2025 Financial and Business Results
- Protalix BioTherapeutics to Announce Second Quarter 2025 Financial and Business Results on August 14, 2025
- Protalix BioTherapeutics Added to Russell 3000® and 2000 Indexes®

